Prophylaxis of Infective Endocarditis: A Cross Sectional Survey among Physician Members of the Portuguese Society of Cardiology


  • Catarina de Sousa Centro Cardiovascular da Universidade de Lisboa. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Lusíadas Knowledge Center – Lusíadas Saúde. Lisboa.
  • Ana G. Almeida Centro Cardiovascular da Universidade de Lisboa. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Departamento de Coração e Vasos. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa.
  • Fausto J. Pinto Centro Cardiovascular da Universidade de Lisboa. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Departamento de Coração e Vasos. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa.



Antibiotic Prophylaxis, Endocarditis, Portugal, Surveys and Questionnaires


Introduction: In the last decade, the downgrading of indications for antibiotic prophylaxis for infective endocarditis caused an uncertain impact on the incidence of this condition. Since no data is available on the practice of infective endocarditis prophylaxis in Portugal, we aimed to characterize the pattern of antibiotic use for infective endocarditis prophylaxis and the compliance/awareness of scientific guidelines among physician members of the Portuguese Society of Cardiology.
Material and Methods: A cross sectional observational study was conducted. An online self-completed questionnaire with 12 items on infective endocarditis prophylaxis was sent to 1330 physicians, specialists and residents, members of the Portuguese Society of Cardiology. In addition, descriptive statistical analysis was performed.
Results: Two hundred and fifty-three valid questionnaires were responded. Eighty-seven per cent of respondents were cardiologists (specialists or residents), mostly between 30 and 40 years old (26.7%) and 50 to 80 years old (44.3%). The majority (83.0%) follow the European scientific guidelines. Still, 61.0% had or may have had doubts regarding prophylaxis of infective endocarditis in certain patients. Variable adherence to scientific guidelines was noted. Further scientific evidence was required by 60.6% of respondents.
Conclusion: Infective endocarditis prophylaxis was generally guided by European scientific guidelines among physicians of the Portuguese Society of Cardiology. There was, however, an evident discrepancy between the guidelines and real-world perception of the risk of infective endocarditis. This highlights the sensed gap in accessing more robust scientific evidence.


Download data is not yet available.


Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017;69:325–44. DOI:

Bin Abdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, et al. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Glob Heart 2014;9:131–43. DOI:

Murdoch DR, Corey GR, Hoen B, Miro J, Fowler V, Bayer A, et al. Clinical presentation, etiology and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Ann Intern Med. 2009;169:463–73. DOI:

Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222–32. DOI:

Lewis T, Grant R. Observations relating to subacute infective endocarditis. Heart. 1923;10:21-77.

Elliott SD. Bacteriæmia and oral sepsis. Proc R Soc Med. 1939;32:747–54. DOI:

Hilson GR. Is chemoprophylaxis necessary? Proc Roy Soc Med. 1970;63:267–71. DOI:

Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015;36:3075–128. DOI:

Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation. 2007;116:1736-54. DOI:

Dayer MJ, Chambers JB, Prendergast B, Sandoe JA, Thornhill MH. NICE guidance on antibiotic prophylaxis to prevent infective endocarditis: a survey of clinicians’ attitudes. QJM. 2013;106:237–43. DOI:

Tarasoutchi F, Montera M, Grinberg M, Barbosa M, Piñeiro D, Sánchez C, et al. Diretriz brasileira de valvopatias - SBC 2011/ I Diretriz interamericana de valvopatias - SIAC 2011. Arq Bras Cardiol. 2011;97:1-67. DOI:

Torres F, Renilla A, Florez J, Secades S, Benito E, de la Hera J. Knowledge of infective endocarditis and prophylaxis among Spanish dentists. Rev Esp Cardiol. 2012;65:1134–5. DOI:

Cloitre A, Duval X, Hoen B, Alla F. A nationwide survey of French dentists’ knowledge and implementation of current guidelines for antibiotic prophylaxis of infective endocarditis in patients with. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:295–303. DOI:

Khan O, Shafi AM, Timmis A. International guideline changes and the incidence of infective endocarditis: a systematic review. Open Heart. 2016;3:e000498. DOI:

Keller K, Bardeleben RS Von, Ostad MA, Hobohm L, Munzel T, Konstantinides S, et al. Temporal trends in the prevalence of infective endocarditis in Germany between 2005 and 2014. Am J Cardiol. 2017;119:317–22. DOI:

Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015;385:1219–28.

Sousa C, Nogueira P, Pinto FJ. Insight into the epidemiology of infective endocarditis in Portugal: a contemporary nationwide study from 2010 to 2018. BMC Cardiovasc Disord. 2021;21:138. DOI:

de Sousa C, Ribeiro RM, Pinto FJ. The burden of infective endocarditis in Portugal in the last 30 years – a systematic review of observational studies. Rev Port Cardiol. 2021;40:205–17. DOI:

Abdulaziz K, Brehaut J, Taljaard M, Émond M, Sirois MJ, Lee JS, et al. National survey of physicians to determine the effect of unconditional incentives on response rates of physician postal surveys. BMJ Open. 2015;5:1–6. DOI:

Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86. DOI:

Metcalfe D, Pitkeathley C, Herring J. ‘Advice, not orders’? The evolving legal status of clinical guidelines. J Med Ethics. 2020;medethics-2020-106592. doi: 10.1136/medethics-2020-106592. DOI:

National Institute for Health and Care Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. 2008. [cited 2019 May 16]. Available from:

Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369–413. DOI:

Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. An increase in the incidence of infective endocarditis in England since 2008: a secular trend interrupted time series analysis. Lancet. 2015;385:1219–28. DOI:

Van Den Brink FS, Swaans MJ, Hoogendijk MG, Alipour A, Kelder JC, Jaarsma W, et al. Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands. Eur Hear J Qual Care Clin Outcomes. 2017;3:141–7. DOI:

Cahill TJ, Harrison JL, Jewell P, Onakpoya I, Chambers JB, Dayer M, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017;103:937–44. DOI:

Grattan MJ, Power A, Fruitman DS, Islam S, Mackie AS. The impact of infective endocarditis prophylaxis recommendations on the practices of pediatric and adult congenital cardiologists. J Cardiol. 2015;31:1497. e23-8. DOI:

Pharis CS, Conway J, Warren AE, Bullock A, MacKie AS. The impact of 2007 infective endocarditis prophylaxis guidelines on the practice of congenital heart disease specialists. Am Heart J. 2011;161:123–9. DOI:

Armstrong ML, DeBoer S, Cetta F. Infective endocarditis after body art: a review of the literature and concerns. J Adolesc Health. 2008;43:217–25. DOI:

Thornhill MH, Jones S, Prendergast B, Baddour LM, Chambers JB, Lockhart PB, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018;39:586–95. DOI:

Sun YP, O’Gara PT. Cardiovascular conditions predisposing to infective endocarditis: time to reconsider the current risk classification system? Eur Heart J. 2018;39:596–8. DOI:

Everett E, Hirschmann J. Transient bacteriemia and endocarditis prophylaxis. a review. Medicine. 1977;56:61–77. DOI:

Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117:3118–25. DOI:

Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG. Infective endocarditis. Nat Rev Dis Prim. 2017;2:1–49. DOI:

McFarlane E, Olmsted MG, Murphy J, Hill CA. Nonresponse bias in a mail survey of physicians. Eval Heal Prof. 2007;30:170–85. DOI:



How to Cite

de Sousa C, Almeida AG, Pinto FJ. Prophylaxis of Infective Endocarditis: A Cross Sectional Survey among Physician Members of the Portuguese Society of Cardiology. Acta Med Port [Internet]. 2022 Jun. 9 [cited 2022 Dec. 10];35(12):874-80. Available from: